Formycon And Bioeq Offer Ranibizumab Update

Partners Set Out Next Steps For Lucentis Biosimilar In US And EU

 
• By David Wallace
  
US EU Flags Gears Europe
The FYB201 ranibizumab biosimilar is in the works for the US and Europe • Source: Shutterstock

More from Biosimilars

More from Products